Article
Increase in future remnant liver function after preoperative portal vein embolization.
Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.
British Journal of Surgery (impact factor:
4.61).
06/2011;
98(6):825-34.
DOI:10.1002/bjs.7456
pp.825-34
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Liver remnant hypertrophy induction - how often do we really use it in the time of computer assisted surgery?
[show abstract] [hide abstract]
ABSTRACT: ABSTRACT Purpose: To evaluate the significance of the hypertrophy concept in patients requiring extended liver resections for colorectal metastasis in the time of computer assisted surgery. Methods: Retrospective analysis of patient collective undergoing major liver surgery. 2D CT, 3D CAS with Fraunhofer MeVis Sofware. Portal vein embolisation (PVE) with the Amplazer Plug, portal vein ligation (PVL) as 1. Stage operative procedure. Results: 2D CT data identified 29 patients out of 319 (2002-2009) to be at risk for liver failure after resection. After 3D CAS analysis and virtual operation planning, only 7/29 were at true risk and were submitted to portal vein occlusion (PVO). Another 5 patients were submitted to the hypertrophy concept for intraoperative finding of insufficient parenchyma quality. In total, 12 patients underwent PVO (6 PVE/6 PVL). 9/12 patients went to stage 2 and were successfully operated. There was no difference in future remnant liver volume (FRLV) gain or waiting time to step 2 between the groups, though survival was better in the PVE group. Conclusion: PVO is an effective approach if the patient's future remnant liver (FRL) is too small on 2D CT volumetry. 3D CAS has great impact on the analysis of FRL capacity and in augmenting resectability - in our experience only patients with insufficient FRLV on the virtual resection plan have to take the risk of PVO to maintain the chance of liver resection.Advances in Medical Sciences 01/2013;
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
3-4 weeks
cent
computed tomography volumetry
FRL
FRL function
FRL volume
hypothetical model
insufficient future remnant liver
liver disease
measure FRL volume
Preoperative portal vein embolization
safe resectability
safe resection
safe resection 3-4 weeks
single photon emission computed tomography
standardized FRL
sufficient increase
total liver volume
uptake
volumetric parameters